• Home
  • About
    • About the COE
      • Mission and Scope of Work
      • COE Funding Acceptance Policy
      • PDMP Grant Applications Policy
    • Expert Panel
      • Expert Panel Membership
      • Expert Panel Activities
    • Staff
  • The Problem
    • The Drug Abuse Epidemic
    • Addressing the Problem
  • Clearinghouse
    • Document Library
    • Reviews, Analyses & Summaries
    • Web Links
    • Media Resources
  • News
  • Work
    • COE Products
      • Notes from the Field
      • Management Tools
      • Study Analyses
    • Presentations
  • Performance
    • PMP Effectiveness
    • PMP Evaluations
    • PMP Best Practices
  • Contact

Search

Home

Which indicators can public health authorities use to monitor prescription drug abuse and evaluate the impact of regulatory measures? Controlling High Dosage Buprenorphine abuse.

Author: 

Pauly, V., Frauger, E., Pradel, V., Rouby, F., Berbis, J., Natali, F., Reggio, P., Coudert, H., Micallef, J., Thirion, X.

Publication Date: 

Jan 1, 2011

Publication: 
Drug and Alcohol Dependence, 113(1):29-36.
Read the abstract
Tags: buprenorphine, doctor shopping, France, journal article, regulating medical practice, thresholds

HOME | ABOUT | THE PROBLEM | CLEARINGHOUSE | NEWS | WORK | PERFORMANCE | CONTACT | SITE MAP |
© 2010-2012 Brandeis University, PMP Center of Excellence. All Rights Reserved.
The COE is a joint project of the Institute of Behavioral Health at Brandeis University, and the Bureau of Justice Assistance.

BJA Logo

Developed and hosted by Resonate Communications, Boston 1-617-340-6333